# Targeted Fortification of Donor Breast Milk in Preterm Infants

> **NCT04294368** · NA · RECRUITING · sponsor: **Columbia University** · enrollment: 50 (estimated)

## Conditions studied

- Prematurity; Extreme
- Failure to Thrive in Newborn
- Growth Retardation
- Growth Failure
- Infant Nutrition Disorders

## Interventions

- **DIETARY_SUPPLEMENT:** Similac Human Milk Fortifier Extensively Hydrolyzed Protein Concentrated Liquid
- **DIETARY_SUPPLEMENT:** Similac Liquid Protein Fortifier
- **DIETARY_SUPPLEMENT:** Nestle Microlipid
- **DIETARY_SUPPLEMENT:** Medica Nutrition SolCarb
- **DIETARY_SUPPLEMENT:** Similac Human Milk Fortifier Extensively Hydrolyzed Protein Concentrated Liquid (Targeted Fortification)
- **DIETARY_SUPPLEMENT:** Similac Liquid Protein Fortifier (Targeted Fortification)
- **DIETARY_SUPPLEMENT:** Nestle Microlipid (Targeted Fortification)
- **DIETARY_SUPPLEMENT:** Medica Nutrition SolCarb (Targeted Fortification)
- **OTHER:** Analysis with Miris (AB) Human Milk Analyzer

## Key facts

- **NCT ID:** NCT04294368
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-09
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04294368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04294368, "Targeted Fortification of Donor Breast Milk in Preterm Infants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04294368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*